Zeugma Hyperbaric Chamber Price: 2026 Cost Breakdown and Buying Guide

The Zeugma hyperbaric chamber is manufactured by HPO Tech in Turkey and targets clinical and premium wellness markets. HPO Tech does not publish a list price; buyers request quotes through its contact form or cost calculator, or through US distributor Atlanta Hyperbaric Center. Benchmarked against published prices for comparable monoplace hard-shell chambers (roughly $40,000 for imported 2.0 ATA units up to $75,000+ for US-made clinical systems), the Zeugma likely runs $40,000 to $80,000+ depending on pressure variant, certifications, and customization.¹³

What Is the Zeugma Hyperbaric Chamber?

The Zeugma is a monoplace hard-shell hyperbaric chamber made by HPO Tech, a Turkish medical device manufacturer. HPO Tech lists three operating pressure options (2.0, 2.4, and 3.0 ATA), which places the Zeugma in clinical territory that soft-shell chambers cannot reach. The vessel is built from 5 mm sandblasted aluminum coated with flame-retardant medical-grade epoxy paint, with custom color and finish options for wellness settings.¹ HPO Tech’s certification portfolio includes CE marking under the EU Medical Device Regulation, ASME PVHO and U-Stamp, UKCA, and ISO 13485.¹

How Much Does a Zeugma Hyperbaric Chamber Cost?

There is no published Zeugma price. HPO Tech states directly that it does not publish a list price and asks buyers to request a quote.¹ The $40,000 to $80,000+ estimate below is anchored to published and typical quoted prices for comparable monoplace hard-shell chambers, compiled in the BaricBoost hyperbaric chamber cost guide.

The Zeugma’s 2.0 ATA baseline configuration should land near the imported-chamber end of that table, while a 3.0 ATA unit with Medical CE and ASME PVHO-1 certification moves toward Sechrist territory. For a full breakdown of what new chambers cost by type, see our guide to hyperbaric chamber purchase costs.

What Factors Affect Zeugma Pricing?

Six variables move a Zeugma quote, and most of them are certification and logistics rather than the vessel itself.

The 2.0 ATA model is the entry point and covers most wellness and recovery applications. The 2.4 and 3.0 ATA variants serve clinical operators treating wound care and other indications at standard treatment pressures. ASME PVHO-1 (Pressure Vessels for Human Occupancy) is the engineering standard for hyperbaric chamber construction; it is voluntary but US clinical operators typically require it.⁵

The Zeugma’s pitch is unusual: one product line spanning wellness-grade and clinical-grade pressures from a single manufacturer, with optional ASME PVHO-1 and Medical CE certification. That is the main reason quotes vary so widely between configurations.

Is the Zeugma Chamber FDA Cleared?

No. A search of the FDA 510(k) database returns no clearances for the Zeugma or for HPO Tech.⁴ The chamber holds CE marking and ASME PVHO certification, but it cannot be marketed as an FDA-cleared medical device in the US, and US clinics cannot use it for insurance-billed treatment of FDA-recognized indications. Perry Baromedical and Sechrist Industries are the leading FDA-cleared clinical chamber manufacturers in the US. For wellness facilities operating outside insurance billing, CE plus ASME PVHO-1 provides comparable engineering rigor, but buyers making medical claims need FDA-cleared equipment.

How Do You Get a Zeugma Quote?

HPO Tech runs a cost calculator at hpotech.com that models setup costs, session revenue, and break-even timelines for chamber buyers, and takes quote requests through its contact form.² US buyers can also contact Atlanta Hyperbaric Center, which carries the Zeugma in its North American product lineup.³ Expect several weeks of lead time for quotes on custom-specification units, and get the certification package (Medical CE, ASME PVHO-1) itemized in writing before comparing against US-made alternatives.

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website